Global Hyperhidrosis Treatment Market Size by Treatment Type, Hyperhidrosis Type, End User, and Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2029

5.67%
CAGR (2023-2029)
1.49 USD Bn.
Market Size
313
Report Pages
163
Market Tables

Overview

Hyperhidrosis Treatment Market size is expected to reach nearly US $ 2.20 Bn by 2029 with the CAGR of 5.67% during the forecast period.

Hyperhidrosis is a chronic disorder of unnecessary sweating beyond thermoregulatory necessities and environmental circumstances. It generally develops in childhood and adolescence, and can affect patients for long duration. Maximum cases of hyperhidrosis include areas of high eccrine (sweat gland) density, mostly in the armpits, palms and soles, and less often in the facial area. As per the International Hyperhidrosis Society (IHS), the global predominant population of hyperhidrosis is xx Mn.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.Hyperhidrosis Treatment MarketTo know about the Research Methodology :- Request Free Sample Report

The scope of the report includes a detailed study of global and regional markets for Hyperhidrosis Treatment with all reasons given for variants in the growth of the industry in certain regions.

The severity and prevalence are primary factors responsible for increase in demand for effective hyperhidrosis treatment in forecast period. Market players will experience persistent pressures to promote the awareness about disease and accessibility of effective hyperhidrosis treatments among patients. Although, the potential increase in awareness will lift the growth of hyperhidrosis market in forecast period, the adverse effects of these treatments will give intensification to the requirement for technologically advanced and harmless treatments. For instance, relevant treatments like aluminum chloride antiperspirants are effective for short duration, but may lead to adverse effects such as intolerable skin irritation. Therefore, recent hyperhidrosis treatment alternatives are initiating the necessity for innovative options like laser therapy, topical botulinum toxin type A, and micro-focused ultrasound treatment which will drive the future market in forecast period.

Hyperhidrosis Treatment market covers segments such as Treatment Type, Hyperhidrosis Type, End User and Region. The Treatment Type segment includes Botulinum Toxin A, Iontophoresis, Surgical Treatments, Topical Treatments, Non-surgical Microwave, Energy Destruction of Sweat Glands and Others. Among the Treatment Type, Botulinum Toxin A is accounted for the largest xx% market share in the Hyperhidrosis Treatment market. The Hyperhidrosis Type segment is further sub-segmented into Axillary Hyperhidrosis, Palmar Hyperhidrosis, Plantar Hyperhidrosis and Others. Among the Hyperhidrosis Type, Axillary Hyperhidrosis is accounted for the largest xx% market share in the Hyperhidrosis Treatment market. Based on End User, the Hyperhidrosis Treatment market is sub-segmented into Hospitals, Ambulatory Surgical Centers and Others. Amongst them Hospitals are accounted for the largest xx% market share in the global market.

Based on regional segment, the global Hyperhidrosis Treatment market is sub-segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America was the foremost market for hyperhidrosis treatment in 2022. Among the key emerged countries, the U.S. has the maximum number of circumstances of hyperhidrosis. Approximate 65% of these patients undergo from axillary hyperhidrosis. These factors are projected to drive the growth of hyperhidrosis treatment market in the region. In U.S., present disease trends specify that, the number of individuals suffering from several types of hyperhidrosis will rise at a rapid rate in forecast period. Asia-Pacific market is anticipated to persist their highest growth rate during 2023-2029, and is projected to register a CAGR of xx%; due to improved technological advancements in producing safe and side effect free treatment substitutions and funding provided by the government and private organizations. Similarly, increased investment by the biotechnology and pharmaceutical companies is projected to upsurge the industry demand.

Key players operating in the Hyperhidrosis Treatment market are Allergan, Brickell Biotech, Inc., Dermira, Inc., GlaxoSmithKline plc., Revance Therapeutics , Inc., Ulthera, Inc., Dr. August Wolff GmbH, TheraVida, Sientra Inc., Miramar Labs, Inc.

The companies functioning in the market are concentrating on R&D investments and fund raising activities to drive clinical trials that lead to robust product pipeline. As detection rate and market perception withstand to expand, there are anticipations for market growth during forecast period. Furthermore, innovative product sanctions in the market will further drive the market growth.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Hyperhidrosis Treatment market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by Product, price, financial position, Product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the Hyperhidrosis Treatment market.

Hyperhidrosis Treatment Market Scope: Inquire before buying

Global Hyperhidrosis Treatment Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.49 Bn.
Forecast Period 2023 to 2029 CAGR: 5.67% Market Size in 2029: US $ 2.20 Bn.
Segments Covered: by Treatment Type Botulinum Toxin A
Iontophoresis
Surgical Treatments
Topical Treatments
Non-surgical Microwave Energy Destruction of Sweat Glands
Others
by Hyperhidrosis Type Axillary Hyperhidrosis
Palmar Hyperhidrosis
Plantar Hyperhidrosis
Others
by End User Hospitals
Ambulatory Surgical Centers
Others

by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Hyperhidrosis Treatment Market Key Players

1. Brickell Biotech, Inc.
2. Dermira, Inc.
3. GlaxoSmithKline plc.
4. Revance Therapeutics , Inc.
5. Ulthera, Inc.
6. Dr. August Wolff GmbH
7. TheraVida, Sientra Inc.
8. Miramar Labs, Inc.
9. NovaMedica.
10.Ulthera, Inc.
11.Allergan
12.Sientra Inc.
13.AbbVie Inc
14.Cynosure
15.Dermadry Laboratories lnc.
16.Sesderma

Frequently Asked Questions:

1. Which region has the largest share in Global Hyperhidrosis Treatment Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Hyperhidrosis Treatment Market?
Ans: The global market is growing at a CAGR of 5.67% during forecasting period 2023-2029.

3. What is scope of the Global Hyperhidrosis Treatment market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Hyperhidrosis Treatment market?
Ans: The important key players in the Global Hyperhidrosis Treatment Market are – Brickell Biotech, Inc., Dermira, Inc., GlaxoSmithKline plc., Revance Therapeutics , Inc., Ulthera, Inc., Dr. August Wolff GmbH, TheraVida, Sientra Inc., Miramar Labs, Inc., NovaMedica., Ulthera, Inc., Allergan, Sientra Inc., AbbVie Inc, Cynosure, Dermadry Laboratories lnc., and Sesderma

5. What is the study period of this market?
Ans: The Global Hyperhidrosis Treatment Market is studied from 2022 to 2029.

Table of Contents

Global Hyperhidrosis Treatment Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Hyperhidrosis Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Hyperhidrosis Treatment Market Analysis and Forecast 6.1. Global Hyperhidrosis Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Hyperhidrosis Treatment Market Analysis and Forecast, By Treatment Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Hyperhidrosis Treatment Market Value Share Analysis, By Treatment Type 7.4. Global Hyperhidrosis Treatment Market Size (US$ Bn) Forecast, By Treatment Type 7.5. Global Hyperhidrosis Treatment Market Analysis, By Treatment Type 7.6. Global Hyperhidrosis Treatment Market Attractiveness Analysis, By Treatment Type 8. Hyperhidrosis Treatment Market Analysis and Forecast, By Hyperhidrosis Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Hyperhidrosis Treatment Market Value Share Analysis, By Hyperhidrosis Type 8.4. Global Hyperhidrosis Treatment Market Size (US$ Bn) Forecast, By Hyperhidrosis Type 8.5. Global Hyperhidrosis Treatment Market Analysis, By Hyperhidrosis Type 8.6. Global Hyperhidrosis Treatment Market Attractiveness Analysis, By Hyperhidrosis Type 9. Hyperhidrosis Treatment Market Analysis and Forecast, By End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Hyperhidrosis Treatment Market Value Share Analysis, By End User 9.4. Global Hyperhidrosis Treatment Market Size (US$ Bn) Forecast, By End User 9.5. Global Hyperhidrosis Treatment Market Analysis, By End User 9.6. Global Hyperhidrosis Treatment Market Attractiveness Analysis, By End User 10. Hyperhidrosis Treatment Market Analysis, by Region 10.1. Global Hyperhidrosis Treatment Market Value Share Analysis, by Region 10.2. Global Hyperhidrosis Treatment Market Size (US$ Bn) Forecast, by Region 10.3. Global Hyperhidrosis Treatment Market Attractiveness Analysis, by Region 11. North America Hyperhidrosis Treatment Market Analysis 11.1. Key Findings 11.2. North America Hyperhidrosis Treatment Market Overview 11.3. North America Hyperhidrosis Treatment Market Value Share Analysis, By Treatment Type 11.4. North America Hyperhidrosis Treatment Market Forecast, By Treatment Type 11.4.1. Botulinum Toxin A 11.4.2. Iontophoresis 11.4.3. Surgical Treatments 11.4.4. Topical Treatments 11.4.5. Non-surgical Microwave Energy Destruction of Sweat Glands 11.4.6. Others 11.5. North America Hyperhidrosis Treatment Market Value Share Analysis, By Hyperhidrosis Type 11.6. North America Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 11.6.1. Axillary Hyperhidrosis 11.6.2. Palmar Hyperhidrosis 11.6.3. Plantar Hyperhidrosis 11.6.4. Others 11.7. North America Hyperhidrosis Treatment Market Value Share Analysis, By End User 11.8. North America Hyperhidrosis Treatment Market Forecast, By End User 11.8.1. Hospitals 11.8.2. Ambulatory Surgical Centers 11.8.3. Others 11.9. North America Hyperhidrosis Treatment Market Value Share Analysis, by Country 11.10. North America Hyperhidrosis Treatment Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Hyperhidrosis Treatment Market Analysis, by Country 11.12. U.S. Hyperhidrosis Treatment Market Forecast, By Treatment Type 11.12.1. Botulinum Toxin A 11.12.2. Iontophoresis 11.12.3. Surgical Treatments 11.12.4. Topical Treatments 11.12.5. Non-surgical Microwave Energy Destruction of Sweat Glands 11.12.6. Others 11.13. U.S. Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 11.13.1. Axillary Hyperhidrosis 11.13.2. Palmar Hyperhidrosis 11.13.3. Plantar Hyperhidrosis 11.13.4. Others 11.14. U.S. Hyperhidrosis Treatment Market Forecast, By End User 11.14.1. Hospitals 11.14.2. Ambulatory Surgical 11.14.3. Others 11.15. Canada Hyperhidrosis Treatment Market Forecast, By Treatment Type 11.15.1. Botulinum Toxin A 11.15.2. Iontophoresis 11.15.3. Surgical Treatments 11.15.4. Topical Treatments 11.15.5. Non-surgical Microwave Energy Destruction of Sweat Glands 11.15.6. Others 11.16. Canada Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 11.16.1. Axillary Hyperhidrosis 11.16.2. Palmar Hyperhidrosis 11.16.3. Plantar Hyperhidrosis 11.16.4. Others 11.17. Canada Hyperhidrosis Treatment Market Forecast, By End User 11.17.1. Hospitals 11.17.2. Ambulatory Surgical Centers 11.17.3. Others 11.18. North America Hyperhidrosis Treatment Market Attractiveness Analysis 11.18.1. By Treatment Type 11.18.2. By Hyperhidrosis Type 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Hyperhidrosis Treatment Market Analysis 12.1. Key Findings 12.2. Europe Hyperhidrosis Treatment Market Overview 12.3. Europe Hyperhidrosis Treatment Market Value Share Analysis, By Treatment Type 12.4. Europe Hyperhidrosis Treatment Market Forecast, By Treatment Type 12.4.1. Botulinum Toxin A 12.4.2. Iontophoresis 12.4.3. Surgical Treatments 12.4.4. Topical Treatments 12.4.5. Non-surgical Microwave Energy Destruction of Sweat Glands 12.4.6. Others 12.5. Europe Hyperhidrosis Treatment Market Value Share Analysis, By Hyperhidrosis Type 12.6. Europe Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 12.6.1. Axillary Hyperhidrosis 12.6.2. Palmar Hyperhidrosis 12.6.3. Plantar Hyperhidrosis 12.6.4. Others 12.7. Europe Hyperhidrosis Treatment Market Value Share Analysis, By End User 12.8. Europe Hyperhidrosis Treatment Market Forecast, By End User 12.8.1. Hospitals 12.8.2. Ambulatory Surgical Centers 12.8.3. Others 12.9. Europe Hyperhidrosis Treatment Market Value Share Analysis, by Country 12.10. Europe Hyperhidrosis Treatment Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Hyperhidrosis Treatment Market Analysis, by Country 12.12. Germany Hyperhidrosis Treatment Market Forecast, By Treatment Type 12.12.1. Botulinum Toxin A 12.12.2. Iontophoresis 12.12.3. Surgical Treatments 12.12.4. Topical Treatments 12.12.5. Non-surgical Microwave Energy Destruction of Sweat Glands 12.12.6. Others 12.13. Germany Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 12.13.1. Axillary Hyperhidrosis 12.13.2. Palmar Hyperhidrosis 12.13.3. Plantar Hyperhidrosis 12.13.4. Others 12.14. Germany Hyperhidrosis Treatment Market Forecast, By End User 12.14.1. Hospitals 12.14.2. Ambulatory Surgical Centers 12.14.3. Others 12.15. U.K. Hyperhidrosis Treatment Market Forecast, By Treatment Type 12.15.1. Botulinum Toxin A 12.15.2. Iontophoresis 12.15.3. Surgical Treatments 12.15.4. Topical Treatments 12.15.5. Non-surgical Microwave Energy Destruction of Sweat Glands 12.15.6. Others 12.16. U.K. Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 12.16.1. Axillary Hyperhidrosis 12.16.2. Palmar Hyperhidrosis 12.16.3. Plantar Hyperhidrosis 12.16.4. Others 12.17. U.K. Hyperhidrosis Treatment Market Forecast, By End User 12.17.1. Hospitals 12.17.2. Ambulatory Surgical Centers 12.17.3. Others 12.18. France Hyperhidrosis Treatment Market Forecast, By Treatment Type 12.18.1. Botulinum Toxin A 12.18.2. Iontophoresis 12.18.3. Surgical Treatments 12.18.4. Topical Treatments 12.18.5. Non-surgical Microwave Energy Destruction of Sweat Glands 12.18.6. Others 12.19. France Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 12.19.1. Axillary Hyperhidrosis 12.19.2. Palmar Hyperhidrosis 12.19.3. Plantar Hyperhidrosis 12.19.4. Others 12.20. France Hyperhidrosis Treatment Market Forecast, By End User 12.20.1. Hospitals 12.20.2. Ambulatory Surgical Centers 12.20.3. Others 12.21. Italy Hyperhidrosis Treatment Market Forecast, By Treatment Type 12.21.1. Botulinum Toxin A 12.21.2. Iontophoresis 12.21.3. Surgical Treatments 12.21.4. Topical Treatments 12.21.5. Non-surgical Microwave Energy Destruction of Sweat Glands 12.21.6. Others 12.22. Italy Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 12.22.1. Axillary Hyperhidrosis 12.22.2. Palmar Hyperhidrosis 12.22.3. Plantar Hyperhidrosis 12.22.4. Others 12.23. Italy Hyperhidrosis Treatment Market Forecast, By End User 12.23.1. Hospitals 12.23.2. Ambulatory Surgical Centers 12.23.3. Others 12.24. Spain Hyperhidrosis Treatment Market Forecast, By Treatment Type 12.24.1. Botulinum Toxin A 12.24.2. Iontophoresis 12.24.3. Surgical Treatments 12.24.4. Topical Treatments 12.24.5. Non-surgical Microwave Energy Destruction of Sweat Glands 12.24.6. Others 12.25. Spain Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 12.25.1. Axillary Hyperhidrosis 12.25.2. Palmar Hyperhidrosis 12.25.3. Plantar Hyperhidrosis 12.25.4. Others 12.26. Spain Hyperhidrosis Treatment Market Forecast, By End User 12.26.1. Hospitals 12.26.2. Ambulatory Surgical Centers 12.26.3. Others 12.27. Rest of Europe Hyperhidrosis Treatment Market Forecast, By Treatment Type 12.27.1. Botulinum Toxin A 12.27.2. Iontophoresis 12.27.3. Surgical Treatments 12.27.4. Topical Treatments 12.27.5. Non-surgical Microwave Energy Destruction of Sweat Glands 12.27.6. Others 12.28. Rest of Europe Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 12.28.1. Axillary Hyperhidrosis 12.28.2. Palmar Hyperhidrosis 12.28.3. Plantar Hyperhidrosis 12.28.4. Others 12.29. Rest of Europe Hyperhidrosis Treatment Market Forecast, By End User 12.29.1. Hospitals 12.29.2. Ambulatory Surgical Centers 12.29.3. Others 12.30. Europe Hyperhidrosis Treatment Market Attractiveness Analysis 12.30.1. By Treatment Type 12.30.2. By Hyperhidrosis Type 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Hyperhidrosis Treatment Market Analysis 13.1. Key Findings 13.2. Asia Pacific Hyperhidrosis Treatment Market Overview 13.3. Asia Pacific Hyperhidrosis Treatment Market Value Share Analysis, By Treatment Type 13.4. Asia Pacific Hyperhidrosis Treatment Market Forecast, By Treatment Type 13.4.1. Botulinum Toxin A 13.4.2. Iontophoresis 13.4.3. Surgical Treatments 13.4.4. Topical Treatments 13.4.5. Non-surgical Microwave Energy Destruction of Sweat Glands 13.4.6. Others 13.5. Asia Pacific Hyperhidrosis Treatment Market Value Share Analysis, By Hyperhidrosis Type 13.6. Asia Pacific Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 13.6.1. Axillary Hyperhidrosis 13.6.2. Palmar Hyperhidrosis 13.6.3. Plantar Hyperhidrosis 13.6.4. Others 13.7. Asia Pacific Hyperhidrosis Treatment Market Value Share Analysis, By End User 13.8. Asia Pacific Hyperhidrosis Treatment Market Forecast, By End User 13.8.1. Hospitals 13.8.2. Ambulatory Surgical Centers 13.8.3. Others 13.9. Asia Pacific Hyperhidrosis Treatment Market Value Share Analysis, by Country 13.10. Asia Pacific Hyperhidrosis Treatment Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Hyperhidrosis Treatment Market Analysis, by Country 13.12. China Hyperhidrosis Treatment Market Forecast, By Treatment Type 13.12.1. Botulinum Toxin A 13.12.2. Iontophoresis 13.12.3. Surgical Treatments 13.12.4. Topical Treatments 13.12.5. Non-surgical Microwave Energy Destruction of Sweat Glands 13.12.6. Others 13.13. China Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 13.13.1. Axillary Hyperhidrosis 13.13.2. Palmar Hyperhidrosis 13.13.3. Plantar Hyperhidrosis 13.13.4. Others 13.14. China Hyperhidrosis Treatment Market Forecast, By End User 13.14.1. Hospitals 13.14.2. Ambulatory Surgical Centers 13.14.3. Others 13.15. India Hyperhidrosis Treatment Market Forecast, By Treatment Type 13.15.1. Botulinum Toxin A 13.15.2. Iontophoresis 13.15.3. Surgical Treatments 13.15.4. Topical Treatments 13.15.5. Non-surgical Microwave Energy Destruction of Sweat Glands 13.15.6. Others 13.16. India Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 13.16.1. Axillary Hyperhidrosis 13.16.2. Palmar Hyperhidrosis 13.16.3. Plantar Hyperhidrosis 13.16.4. Others 13.17. India Hyperhidrosis Treatment Market Forecast, By End User 13.17.1. Hospitals 13.17.2. Ambulatory Surgical Centers 13.17.3. Others 13.18. Japan Hyperhidrosis Treatment Market Forecast, By Treatment Type 13.18.1. Botulinum Toxin A 13.18.2. Iontophoresis 13.18.3. Surgical Treatments 13.18.4. Topical Treatments 13.18.5. Non-surgical Microwave Energy Destruction of Sweat Glands 13.18.6. Others 13.19. Japan Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 13.19.1. Axillary Hyperhidrosis 13.19.2. Palmar Hyperhidrosis 13.19.3. Plantar Hyperhidrosis 13.19.4. Others 13.20. Japan Hyperhidrosis Treatment Market Forecast, By End User 13.20.1. Hospitals 13.20.2. Ambulatory Surgical Centers 13.20.3. Others 13.21. ASEAN Hyperhidrosis Treatment Market Forecast, By Treatment Type 13.21.1. Botulinum Toxin A 13.21.2. Iontophoresis 13.21.3. Surgical Treatments 13.21.4. Topical Treatments 13.21.5. Non-surgical Microwave Energy Destruction of Sweat Glands 13.21.6. Others 13.22. ASEAN Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 13.22.1. Axillary Hyperhidrosis 13.22.2. Palmar Hyperhidrosis 13.22.3. Plantar Hyperhidrosis 13.22.4. Others 13.23. ASEAN Hyperhidrosis Treatment Market Forecast, By End User 13.23.1. Hospitals 13.23.2. Ambulatory Surgical Centers 13.23.3. Others 13.24. Rest of Asia Pacific Hyperhidrosis Treatment Market Forecast, By Treatment Type 13.24.1. Botulinum Toxin A 13.24.2. Iontophoresis 13.24.3. Surgical Treatments 13.24.4. Topical Treatments 13.24.5. Non-surgical Microwave Energy Destruction of Sweat Glands 13.24.6. Others 13.25. Rest of Asia Pacific Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 13.25.1. Axillary Hyperhidrosis 13.25.2. Palmar Hyperhidrosis 13.25.3. Plantar Hyperhidrosis 13.25.4. Others 13.26. Rest of Asia Pacific Hyperhidrosis Treatment Market Forecast, By End User 13.26.1. Hospitals 13.26.2. Ambulatory Surgical Centers 13.26.3. Others 13.27. Asia Pacific Hyperhidrosis Treatment Market Attractiveness Analysis 13.27.1. By Treatment Type 13.27.2. By Hyperhidrosis Type 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Hyperhidrosis Treatment Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Hyperhidrosis Treatment Market Overview 14.3. Middle East & Africa Hyperhidrosis Treatment Market Value Share Analysis, By Treatment Type 14.4. Middle East & Africa Hyperhidrosis Treatment Market Forecast, By Treatment Type 14.4.1. Botulinum Toxin A 14.4.2. Iontophoresis 14.4.3. Surgical Treatments 14.4.4. Topical Treatments 14.4.5. Non-surgical Microwave Energy Destruction of Sweat Glands 14.4.6. Others 14.5. Middle East & Africa Hyperhidrosis Treatment Market Value Share Analysis, By Hyperhidrosis Type 14.6. Middle East & Africa Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 14.6.1. Axillary Hyperhidrosis 14.6.2. Palmar Hyperhidrosis 14.6.3. Plantar Hyperhidrosis 14.7. Middle East & Africa Hyperhidrosis Treatment Market Value Share Analysis, By End User 14.8. Middle East & Africa Hyperhidrosis Treatment Market Forecast, By End User 14.8.1. Hospitals 14.8.2. Ambulatory Surgical Centers 14.8.3. Others 14.9. Middle East & Africa Hyperhidrosis Treatment Market Value Share Analysis, by Country 14.10. Middle East & Africa Hyperhidrosis Treatment Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Hyperhidrosis Treatment Market Analysis, by Country 14.12. GCC Hyperhidrosis Treatment Market Forecast, By Treatment Type 14.12.1. Botulinum Toxin A 14.12.2. Iontophoresis 14.12.3. Surgical Treatments 14.12.4. Topical Treatments 14.12.5. Non-surgical Microwave Energy Destruction of Sweat Glands 14.12.6. Others 14.13. GCC Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 14.13.1. Axillary Hyperhidrosis 14.13.2. Palmar Hyperhidrosis 14.13.3. Plantar Hyperhidrosis 14.13.4. Others 14.14. GCC Hyperhidrosis Treatment Market Forecast, By End User 14.14.1. Hospitals 14.14.2. Ambulatory Surgical Centers 14.14.3. Others 14.15. South Africa Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 14.15.1. Axillary Hyperhidrosis 14.15.2. Palmar Hyperhidrosis 14.15.3. Plantar Hyperhidrosis 14.15.4. Others 14.16. South Africa Hyperhidrosis Treatment Market Forecast, By End User 14.16.1. Hospitals 14.16.2. Ambulatory Surgical Centers 14.16.3. Others 14.17. Rest of Middle East & Africa Hyperhidrosis Treatment Market Forecast, By Treatment Type 14.17.1. Botulinum Toxin A 14.17.2. Iontophoresis 14.17.3. Surgical Treatments 14.17.4. Topical Treatments 14.17.5. Non-surgical Microwave Energy Destruction of Sweat Glands 14.17.6. Others 14.18. Rest of Middle East & Africa Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 14.18.1. Axillary Hyperhidrosis 14.18.2. Palmar Hyperhidrosis 14.18.3. Plantar Hyperhidrosis 14.18.4. Others 14.19. Rest of Middle East & Africa Hyperhidrosis Treatment Market Forecast, By End User 14.19.1. Hospitals 14.19.2. Ambulatory Surgical Centers 14.19.3. Others 14.20. Middle East & Africa Hyperhidrosis Treatment Market Attractiveness Analysis 14.20.1. By Treatment Type 14.20.2. By Hyperhidrosis Type 14.20.3. By End User 14.21. PEST Analysis 14.22. Key Trends 14.23. Key Developments 15. South America Hyperhidrosis Treatment Market Analysis 15.1. Key Findings 15.2. South America Hyperhidrosis Treatment Market Overview 15.3. South America Hyperhidrosis Treatment Market Value Share Analysis, By Treatment Type 15.4. South America Hyperhidrosis Treatment Market Forecast, By Treatment Type 15.4.1. Botulinum Toxin A 15.4.2. Iontophoresis 15.4.3. Surgical Treatments 15.4.4. Topical Treatments 15.4.5. Non-surgical Microwave Energy Destruction of Sweat Glands 15.4.6. Others 15.5. South America Hyperhidrosis Treatment Market Value Share Analysis, By Hyperhidrosis Type 15.6. South America Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 15.6.1. Axillary Hyperhidrosis 15.6.2. Palmar Hyperhidrosis 15.6.3. Plantar Hyperhidrosis 15.6.4. Others 15.7. South America Hyperhidrosis Treatment Market Value Share Analysis, By End User 15.8. South America Hyperhidrosis Treatment Market Forecast, By End User 15.8.1. Hospitals 15.8.2. Ambulatory Surgical Centers 15.8.3. Others 15.9. South America Hyperhidrosis Treatment Market Value Share Analysis, by Country 15.10. South America Hyperhidrosis Treatment Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Hyperhidrosis Treatment Market Analysis, by Country 15.12. Brazil Hyperhidrosis Treatment Market Forecast, By Treatment Type 15.12.1. Botulinum Toxin A 15.12.2. Iontophoresis 15.12.3. Surgical Treatments 15.12.4. Topical Treatments 15.12.5. Non-surgical Microwave Energy Destruction of Sweat Glands 15.12.6. Others 15.13. Brazil Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 15.13.1. Axillary Hyperhidrosis 15.13.2. Palmar Hyperhidrosis 15.13.3. Plantar Hyperhidrosis 15.13.4. Others 15.14. Brazil Hyperhidrosis Treatment Market Forecast, By End User 15.14.1. Hospitals 15.14.2. Ambulatory Surgical Centers 15.14.3. Others 15.15. Mexico Hyperhidrosis Treatment Market Forecast, By Treatment Type 15.15.1. Botulinum Toxin A 15.15.2. Iontophoresis 15.15.3. Surgical Treatments 15.15.4. Topical Treatments 15.15.5. Non-surgical Microwave Energy Destruction of Sweat Glands 15.15.6. Others 15.16. Mexico Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 15.16.1. Axillary Hyperhidrosis 15.16.2. Palmar Hyperhidrosis 15.16.3. Plantar Hyperhidrosis 15.16.4. Others 15.17. Mexico Hyperhidrosis Treatment Market Forecast, By End User 15.17.1. Hospitals 15.17.2. Ambulatory Surgical Centers 15.17.3. Others 15.18. Rest of South America Hyperhidrosis Treatment Market Forecast, By Treatment Type 15.18.1. Botulinum Toxin A 15.18.2. Iontophoresis 15.18.3. Surgical Treatments 15.18.4. Topical Treatments 15.18.5. Non-surgical Microwave Energy Destruction of Sweat Glands 15.18.6. Others 15.19. Rest of South America Hyperhidrosis Treatment Market Forecast, By Hyperhidrosis Type 15.19.1. Axillary Hyperhidrosis 15.19.2. Palmar Hyperhidrosis 15.19.3. Plantar Hyperhidrosis 15.19.4. Others 15.20. Rest of South America Hyperhidrosis Treatment Market Forecast, By End User 15.20.1. Hospitals 15.20.2. Ambulatory Surgical Centers 15.20.3. Others 15.21. South America Hyperhidrosis Treatment Market Attractiveness Analysis 15.21.1. By Treatment Type 15.21.2. By Hyperhidrosis Type 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Hyperhidrosis Types and R&D investment 16.2.2. New Treatment Center Launches and Treatment Center Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Hyperhidrosis Types 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Allergan 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Treatment Center Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. Brickell Biotech, Inc. 16.3.3. Dermira, Inc. 16.3.4. GlaxoSmithKline plc. 16.3.5. Revance Therapeutics , Inc. 16.3.6. Ulthera, Inc. 16.3.7. Dr. August Wolff GmbH 16.3.8. TheraVida, Sientra Inc. 16.3.9. Miramar Labs, Inc. 16.3.10. NovaMedica. 16.3.11. Ulthera, Inc. 16.3.12. Allergan 16.3.13. Sientra Inc. 16.3.14. AbbVie Inc 16.3.15. Cynosure 16.3.16. Dermadry Laboratories lnc. 16.3.17. Sesderma 17. Primary Key Insights

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Request Customization Download Sample